Urology · San Francisco, CA
NPI
1003051780
Since 2008
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
929 Clay St, Suite 505
San Francisco, CA, 94108
Phone (415) 392-9690
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
2,036 services
Medicare patients, 2024
766
Average age 76
Drug cost, 2024
$972K
6,361 prescriptions
Company payments, 2025
$6,743
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wenwu Jin was code 99214 (office e&m - established), 1,078 times for 635 patients. In total Wenwu Jin billed 2,036 services in 48 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,078 | 635 | $95.30 | $103K |
| 99204 Office E&M - New | Office | 175 | 175 | $104.09 | $18K |
| 99213 Office E&M - Established | Office | 164 | 118 | $71.69 | $12K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 144 | 17 | $141.23 | $20K |
| 76872 Ultrasound - Nonspecific | Office | 118 | 117 | $125.00 | $15K |
| 52000 Cystourethroscopy | Office | 68 | 63 | $191.96 | $13K |
| 99215 Office E&M - Established | Office | 54 | 39 | $161.31 | $8,711 |
| 96402 Chemotherapy Administration | Office | 46 | 17 | $33.78 | $1,554 |
| 99212 Office E&M - Established | Office | 34 | 30 | $46.79 | $1,591 |
| 99222 Hospital E&M - Initial | Facility | 17 | 16 | $114.72 | $1,950 |
| 99205 Office E&M - New | Office | 11 | 11 | $173.56 | $1,909 |
By year: 2022 $341K for 2,919 services; 2023 $246K for 2,225 services; 2024 $232K for 2,036 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87798 Infectious Agent Detection by DNA/RNA | 144 | 15 | $34.96 | $5,034 |
| 87801 Infectious Agent Detection by DNA/RNA | 48 | 15 | $69.94 | $3,357 |
| 87591 Infectious Agent Detection by DNA/RNA | 16 | 15 | $34.96 | $559 |
| 87640 Infectious Agent Detection by DNA/RNA | 16 | 15 | $34.96 | $559 |
| 87481 Infectious Agent Detection by DNA/RNA | 16 | 15 | $34.96 | $559 |
| 87653 Infectious Agent Detection by DNA/RNA | 16 | 15 | $34.96 | $559 |
| 87661 Infectious Agent Detection by DNA/RNA | 16 | 15 | $34.96 | $559 |
| 87651 Infectious Agent Detection by DNA/RNA | 16 | 15 | $34.96 | $559 |
| 87491 Infectious Agent Detection by DNA/RNA | 16 | 15 | $34.96 | $559 |
Medicare prescription drug claims, 2024
In 2024, the drug Wenwu Jin prescribed most often to Medicare patients was Tamsulosin Hcl, with 2,782 prescriptions and refills. In total Wenwu Jin wrote 6,361 Medicare prescriptions that cost $972K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 2,782 | 8,086 | 997 | $40K |
| Finasteride Generic | 2,446 | 7,169 | 839 | $29K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 242 | 574 | 145 | $5,500 |
| Ciprofloxacin Hcl Generic | 234 | 234 | 200 | $418 |
| Myrbetriq Mirabegron | 186 | 417 | 89 | $176K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 127 | 127 | 97 | $186 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 83 | 83 | 73 | $318 |
| Xtandi Enzalutamide | 32 | 32 | Under 11 | $366K |
| Terazosin Hcl Generic | 30 | 83 | 13 | $501 |
| Dutasteride Generic | 28 | 84 | Under 11 | $1,965 |
| Doxazosin Mesylate Generic | 22 | 50 | Under 11 | $364 |
| Gemtesa Vibegron | 21 | 38 | Under 11 | $17K |
| Desmopressin Acetate Generic | 17 | 37 | Under 11 | $706 |
| Potassium Citrate Er Potassium Citrate | 13 | 23 | 12 | $1,499 |
| Nubeqa Darolutamide | 12 | 12 | Under 11 | $167K |
Brand drugs: - claims; generic drugs: 6,090 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wenwu Jin $6,743 ($6,743 in general payments such as food, travel and fees) from 16 companies. The largest payer was Intuitive Surgical, Inc. with $4,753.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 13 | $4,753 |
| Procept Biorobotics Corporation PRCT | 8 | $606 |
| Janssen Biotech, Inc. JNJ | 10 | $482 |
| Astellas Pharma US Inc 4503.T | 5 | $275 |
| Ferring Pharmaceuticals Inc. | 3 | $171 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $65.17 |
| Verity Pharmaceuticals Inc. | 2 | $56.62 |
| ABC Home Medical Supply, Inc. | 2 | $56.27 |
| AngioDynamics, Inc. ANGO | 1 | $46.85 |
| Accord Healthcare, Inc. | 2 | $43.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.